Afsaneh Shirani, MD

Assistant Professor

  • 0 Citations
  • 0 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Afsaneh Shirani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Multiple Sclerosis Medicine & Life Sciences
Interferon-beta Medicine & Life Sciences
British Columbia Medicine & Life Sciences
Relapsing-Remitting Multiple Sclerosis Medicine & Life Sciences
Disease Progression Medicine & Life Sciences
Canada Medicine & Life Sciences
Chronic Progressive Multiple Sclerosis Medicine & Life Sciences
Proportional Hazards Models Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

Diffusion basis spectrum imaging for identifying pathologies in MS subtypes

Shirani, A., Sun, P., Trinkaus, K., Perantie, D. C., George, A., Naismith, R. T., Schmidt, R. E., Song, S. K. & Cross, A. H., Nov 1 2019, In : Annals of Clinical and Translational Neurology. 6, 11, p. 2323-2327 5 p.

Research output: Contribution to journalArticle

Open Access
Multiple Sclerosis
Pathology
Biomarkers
Corpus Callosum
Edema

Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report

Shirani, A., Sun, P., Schmidt, R. E., Trinkaus, K., Naismith, R. T., Song, S. K. & Cross, A. H., Dec 1 2019, In : Multiple Sclerosis Journal. 25, 14, p. 1937-1941 5 p.

Research output: Contribution to journalArticle

Biopsy
Brain
Demyelinating Diseases
Multiple Sclerosis
Diffusion Magnetic Resonance Imaging

A case of oligodendroglioma and multiple sclerosis: Occam's razor or Hickam's dictum?

Shirani, A., Wu, G. F., Giannini, C. & Cross, A. H., Jan 1 2018, In : BMJ case reports. 2018, bcr-2018-225318.

Research output: Contribution to journalArticle

Oligodendroglioma
Multiple Sclerosis
Brain
Oligoclonal Bands
Isocitrate Dehydrogenase

Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies

The BeAMS study group, Jun 1 2018, In : Statistical Methods in Medical Research. 27, 6, p. 1709-1722 14 p.

Research output: Contribution to journalArticle

Confounding
Drugs
Time-dependent Covariates
Cox Model
Structural Model

Natalizumab: Perspectives from the bench to bedside

Shirani, A. & Stüve, O., Dec 2018, In : Cold Spring Harbor Perspectives in Medicine. 8, 12, a029066.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Drug Approval
Leukoencephalopathies
Relapsing-Remitting Multiple Sclerosis
Lymphocytes